Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data
CANF Stock Soars 20% on Positive Mid-Stage Pancreatic Cancer Data

Can-Fite BioPharma CANF shares soared 20.4% on Wednesday after the company reported positive top-line results from a mid-stage study of its investigational candidate, namodenoson, in patients with

Zacks 
0 05.03.26